Key result
Wearable open-source ECG systems prove feasible for remote monitoring but require clinical and regulatory validation.
Why the study?
Most of the global cardiovascular disease burden falls on low- and middle-income countries where access to electrocardiography is limited, prompting interest in how low-cost, open-source, and wearable ECG systems are designed and evaluated for remote cardiac monitoring.
Answers are grounded in this paper and cite their sources.
This narrative review concludes that while low-cost, open-source, and wearable ECG systems are technically feasible, their clinical impact now depends on rigorous validation in target populations, signal quality management, and regulatory-grade engineering.
Cardiovascular diseases remain the leading cause of death worldwide, and most of this burden falls on low- and middle-income countries where access to electrocardiography (ECG) is limited. In the last decade, integrated biopotential front ends, open-source microcontroller platforms and ubiquitous smartphones have made it possible to build ECG monitors at a fraction of the cost of conventional equipment, while consumer wearables have shown that single-lead ECG can be recorded at population scale. This narrative review examines how low-cost, open-source and wearable ECG systems are designed and evaluated for remote cardiac monitoring. We describe the end-to-end architecture (electrodes, analog front ends, microcontrollers, wireless links, gateways and cloud back ends), the signal processing chain (denoising, signal quality assessment, QRS detection, delineation and heart rate variability), and the emerging role of artificial intelligence running on the cloud or directly on the device. We then discuss validation methodology, including reference databases, standardized metrics and agreement analysis, and summarize the regulatory, safety and data protection requirements that separate a research prototype from a medical device. An Arduino-based remote ECG system previously developed by the author is used as a reference case to illustrate common design choices and pitfalls. We conclude that technical feasibility is no longer the bottleneck; rigorous validation in target populations, signal quality management and regulatory-grade engineering now determine clinical impact.
No takes yet. Share an insight, caveat, or question.
Roberto Franchini (2026) conducted a review in Cardiovascular diseases requiring remote cardiac monitoring. Low-cost, open-source and wearable ECG systems vs. Conventional ECG equipment was evaluated. Low-cost, open-source, and wearable single-lead ECG systems are technically feasible for remote monitoring, though clinical impact depends on rigorous validation and regulatory-grade engineering.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: